# SBC Medical Group Holdings Incorporated (SBC)

> Source: Nexqual · https://nexqual.com/SBC · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, SBC Medical Group Holdings Incorporated (SBC), nexqual.com/SBC" · informational, not investment advice.

**Price:** USD 5.3 (+1.34% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 5.23 · day 5.11–5.3 · 52w 2.78–5.61 · market cap $545M · NGM

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $175M, net income $49.0M (28.0% margin), free cash flow $61.8M (SEC filings).
- Valuation: P/E 11.1x (avg 15.3x at the last 3 fiscal year-ends), EV/EBITDA 5.9x, net cash $147M.
- Analysts: Buy (mean 1.67 on a 1–5 scale) (3 analysts), mean target USD 8.75 (range 7–11).
- Total return with dividends: 1Y +27.1% vs S&P 500 +18.1%; 5Y -47.1% vs S&P 500 +85.1%.
- Next earnings: 2026-11-13, EPS estimate USD 0.12, revenue estimate $48.9M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2024 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|
| Revenue | $194M | $205M | $174M | $175M |
| Gross profit | $137M | $156M | $127M | — |
| Operating income | $70.7M | $70.3M | $67.5M | $65.4M |
| Net income | $39.4M | $46.6M | $51.0M | $49.0M |
| EPS (diluted) | $0.42 | $0.48 | $0.50 | — |
| Free cash flow | $42.1M | $18.0M | $23.3M | $61.8M |
| Gross margin | 70.9% | 76.0% | 73.3% | — |
| Operating margin | 36.5% | 34.2% | 38.9% | 37.3% |
| Net margin | 20.3% | 22.7% | 29.4% | 28.0% |
| Revenue growth | — | +6.1% | -15.5% | — |
| Cash + short-term investments | $103M | $125M | $164M | — |
| Total debt | — | $6.9M | $43.1M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 11.1x · P/S 3.1x · EV/EBITDA 5.9x · EV/Sales 2.3x · P/FCF 8.8x · P/B 2.1x · FCF yield 11.33% · Earnings yield 8.99% · Net cash $147M · EV $398M
P/E at fiscal year-ends: Dec 2025 8.7x, Dec 2024 11.5x, Dec 2023 25.8x.

## Analysts
Consensus Buy (mean 1.67 on a 1–5 scale), 3 analysts; mean target USD 8.75 (low 7, high 11).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-13 | BTIG | Reiterated | Buy | $8 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2022-09-26) |
|---|---|---|
| Total return | +27.1% | -47.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +27.2% | -14.5% |
| Volatility (annualized) | 55.8% | 70.1% |
| Max drawdown | -41.7% (Feb 2026→May 2026) | -81.0% (May 2024→Jun 2026) |

## Peers (Consulting Services)
ROMA (Roma Green Finance Limited) USD 8.34 -1.42% · PPHC (Public Policy Holding Company, ) USD 10.59 +0.09% · CRAI (CRA International,Inc.) USD 177.35 -0.92% · ICFI (ICF International, Inc.) USD 88.77 +1.52% · HURN (Huron Consulting Group Inc.) USD 175.47 -0.49% · FCN (FTI Consulting, Inc.) USD 146.24 +6.06%

## More
Full page: https://nexqual.com/SBC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt